APA (7th ed.) Citation

Cataldo Martucci, Andrew Dennis Allen, Nadia Moretto, Valentina Bagnacani, Alessandro Fioni, Riccardo Patacchini, . . . Fabrizio Facchinetti. (2024). CHF6297: A novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Cataldo Martucci, Andrew Dennis Allen, Nadia Moretto, Valentina Bagnacani, Alessandro Fioni, Riccardo Patacchini, Maurizio Civelli, Gino Villetti, and Fabrizio Facchinetti. CHF6297: A Novel Potent and Selective P38 MAPK Inhibitor with Robust Anti-inflammatory Activity and Suitable for Inhaled Pulmonary Administration as Dry Powder. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Cataldo Martucci, et al. CHF6297: A Novel Potent and Selective P38 MAPK Inhibitor with Robust Anti-inflammatory Activity and Suitable for Inhaled Pulmonary Administration as Dry Powder. Frontiers Media S.A., 2024.